• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT RX HERCULINK ELITE STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT RX HERCULINK ELITE STENT SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Intimal Dissection (1333); Embolism (1829); Hemorrhage/Bleeding (1888); Ischemia (1942); Pain (1994); Perforation (2001)
Event Date 08/19/2014
Event Type  Injury  
Event Description
It was reported through a research article identifying the herculink elite stent that may be related to the following: discomfort during balloon inflation, retroperitoneal hemorrhage, renal artery perforation, arterial and aortic dissection, atheromatous embolization, and renal infarctions.Specific patient information is documented as unknown.Details are listed in the attached article, titled "scai expert consensus statement for renal artery stenting appropriate use".
 
Manufacturer Narrative
(b)(4).The devices are not returning and there was no reported device malfunction.Review of the lot history record could not be conducted because the lot numbers were not provided.The reported patient effects of dissection, embolism, hemorrhage, perforation, kidney infarct, and pain are known observed and potential patient effects as listed in the rx herculink elite instructions for use.Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.Sahil a.Parikh,1 md, facc, fscai ; mehdi h.Shishehbor, do, mph, facc, fscai; bruce h.Gray, do, fscai; christopher j.White, md, facc, fscai and michael r.Jaff, do, facc, fscai.(catheterization and cardiovascular interventions 00:00-00 (2014)): scai expert consensus statement for renal artery stenting appropriate use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key4164185
MDR Text Key4872518
Report Number2024168-2014-06610
Device Sequence Number1
Product Code NIN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial
Report Date 08/22/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/16/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability;
-
-